Hm Payson & CO Haleon PLC Transaction History
Hm Payson & CO
- $5.79 Billion
- Q4 2024
A detailed history of Hm Payson & CO transactions in Haleon PLC stock. As of the latest transaction made, Hm Payson & CO holds 1,810 shares of HLN stock, worth $19,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,810
Previous 1,810
-0.0%
Holding current value
$19,312
Previous $19,000
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HLN
# of Institutions
662Shares Held
432MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.91 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$350 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$257 Million1.6% of portfolio
-
Wellington Management Group LLP Boston, MA15.3MShares$164 Million0.03% of portfolio
-
Morgan Stanley New York, NY9.89MShares$106 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $49.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...